OCT 12, 2017 06:00 AM PDT

Disparities in Colorectal Cancer

C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • John G Searle Professor of Internal Medicine, Professor and Chair Department of Internal Medicine, Professor of Human Genetics, UMHS Internal Medicine, University of Michigan

Abstract:

Colorectal cancer (CRC) is the third most common cancer among Americans, and the second deadliest. Its pathogenesis results from an interplay between environmental factors that influence biological behavior of colonic stem cells, and the genetic makeup of susceptible individuals. Activation of stem cell proliferation from this interplay eventually yields adenomatous polyps, which if not removed after detection through an effective screening program, may further progress to cancers that may metastasize and affect survival. This normal-to-polyp-to-cancer process appears to occur at different initiation ages and progresses at different rates among various races in the United States, with African Americans demonstrating the highest incidence and mortality for CRC among all races. Compared with Caucasians, African American CRC patients tend to present at a younger age, have a more proximal cancer, present with more advanced stage, and show shortened survival. In parallel, African Americans demonstrate higher risk adenomatous polyps and more proximally-located polyps than Caucasians as the precursor lesions to CRC. There are likely multifactorial factors that contribute to this disparity, including socio-economic, health insurance, and educational factors, CRC screening utilization, diet, obesity, and microbiome makeup of the colon, tobacco utilization, use of NSAIDs and hormone replacement therapy, and differences in biology of the tumor and/or metastasis. Increasing CRC screening rates towards 80% utilization or greater for African Americans suggests that this disparity may be lessened or disappear. Other strategies such as enhanced patient and physician education and patient navigation for colonoscopy may also reduce the disparity. The U.S. Multi-Society Task Force on Colorectal Cancer, for the first time as of July 2017, endorsed lowering the screening age for African Americans from 50 years of age to 45 years of age, an age where the proportion of CRCs below age 45 years matches the proportion of CRCs among Caucasians below 50 years of age. Employment of these and other strategies may further mitigate the observed disparities.


Show Resources
You May Also Like
MAY 24, 2018 09:30 AM PDT
C.E. CREDITS
MAY 24, 2018 09:30 AM PDT
DATE: May 24, 2018 TIME: 9:30PM PDT The current gold standard in in vitro pre-clinical cancer treatment screening remain cell lines,...
APR 27, 2018 10:00 AM PDT
C.E. CREDITS
APR 27, 2018 10:00 AM PDT
DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
AUG 15, 2018 08:00 AM PDT
C.E. CREDITS
AUG 15, 2018 08:00 AM PDT
DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
JUN 29, 2018 09:00 AM PDT
C.E. CREDITS
JUN 29, 2018 09:00 AM PDT
DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
MAY 02, 2018 08:00 AM PDT
C.E. CREDITS
MAY 02, 2018 08:00 AM PDT
Immunohistochemistry protocols, which utilize antibodies to visualize proteins in tissue sections, have many steps that need optimized to prevent non-specific background effects, artifacts, o...
MAY 29, 2018 09:00 AM PDT
C.E. CREDITS
MAY 29, 2018 09:00 AM PDT
Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
Loading Comments...